DK2182920T3 - Stabil væskeformig farmaceutisk komposition baseret på trazodon - Google Patents

Stabil væskeformig farmaceutisk komposition baseret på trazodon

Info

Publication number: DK2182920T3
Authority: DK; Denmark
Prior art keywords: trazodone; pharmaceutical composition; liquid pharmaceutical; composition based; stable liquid
Prior art date: 2007-07-31

Application number

DK08775278.8T

Other languages

English (en)

Inventor

Marcello Marchetti

Francesca Mariotti

Lorella Ragni

Paolo Scarpetti

Mauro Valenti

Original Assignee

Acraf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-31

Filing date

2008-07-22

Publication date

2013-03-04

2008-07-22 Application filed by Acraf filed Critical Acraf

2013-03-04 Application granted granted Critical

2013-03-04 Publication of DK2182920T3 publication Critical patent/DK2182920T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Physiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK08775278.8T 2007-07-31 2008-07-22 Stabil væskeformig farmaceutisk komposition baseret på trazodon DK2182920T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT001573A ITMI20071573A1 (it)	2007-07-31	2007-07-31	Composizione farmaceutica liquida stabile a base di trazodone
PCT/EP2008/059605 WO2009016069A2 (en)	2007-07-31	2008-07-22	Stable liquid pharmaceutical composition based on trazodone

Publications (1)

Publication Number	Publication Date
DK2182920T3 true DK2182920T3 (da)	2013-03-04

Family

ID=38858941

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK12170235T DK2494955T3 (da)	2007-07-31	2008-07-22	Stabil væskeformig farmaceutisk komposition baseret på tradozone.
DK08775278.8T DK2182920T3 (da)	2007-07-31	2008-07-22	Stabil væskeformig farmaceutisk komposition baseret på trazodon

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK12170235T DK2494955T3 (da)	2007-07-31	2008-07-22	Stabil væskeformig farmaceutisk komposition baseret på tradozone.

Country Status (23)

Country	Link
US (1)	US10292931B2 (da)
EP (2)	EP2182920B1 (da)
JP (1)	JP5426548B2 (da)
KR (1)	KR101493370B1 (da)
CN (1)	CN101784257B (da)
AR (1)	AR068327A1 (da)
AU (1)	AU2008281858B2 (da)
CA (1)	CA2692975C (da)
CY (1)	CY1116189T1 (da)
DK (2)	DK2494955T3 (da)
EA (1)	EA016822B1 (da)
ES (2)	ES2399569T3 (da)
GE (1)	GEP20125525B (da)
HR (1)	HRP20150349T1 (da)
IL (1)	IL203167A (da)
IT (1)	ITMI20071573A1 (da)
MX (1)	MX2010001092A (da)
PL (2)	PL2494955T3 (da)
PT (2)	PT2182920E (da)
SG (1)	SG183659A1 (da)
SI (2)	SI2494955T1 (da)
UA (1)	UA102376C2 (da)
WO (1)	WO2009016069A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20071603A1 (it)	2007-08-03	2009-02-04	Acraf	Trazodone e trazodone cloridrato in forma purificata
WO2012072665A1 (en)	2010-11-30	2012-06-07	Pharmaneuroboost N.V.	Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
RU2706700C1 (ru) *	2019-09-24	2019-11-20	Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ"	Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях
GEP20257739B (en) *	2019-09-26	2025-02-25	Angelini S P A	Pediatric trazodone compositions
CN111568861A (zh) *	2020-05-25	2020-08-25	河北科星药业有限公司	畜禽用盐酸溴己新口服液及其制备方法和应用
WO2024220372A1 (en) *	2023-04-15	2024-10-24	Rubicon Research Private Limited	Liquid formulations of trazodone
CN119280155B (zh) *	2024-12-11	2025-02-25	新基元(北京)医药科技有限公司	一种改善稳定性的盐酸曲唑酮液体药物组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4154832A (en)	1974-08-26	1979-05-15	Bruno Silvestrini	Novel treatment for acute organic cerebral syndromes (strokes)
IT1233412B (it) *	1987-12-02	1992-03-30	Acraf	Uso del trazodone
ATE292956T1 (de) *	1998-07-24	2005-04-15	Seo Hong Yoo	Klare wässrige lösungen enthaltend gallensäuren
AU2003903597A0 (en)	2003-07-11	2003-07-24	Jakov Vaisman	Treatment of premature ejaculation
ITMI20071603A1 (it)	2007-08-03	2009-02-04	Acraf	Trazodone e trazodone cloridrato in forma purificata

2007
- 2007-07-31 IT IT001573A patent/ITMI20071573A1/it unknown
2008
- 2008-07-22 MX MX2010001092A patent/MX2010001092A/es active IP Right Grant
- 2008-07-22 DK DK12170235T patent/DK2494955T3/da active
- 2008-07-22 EP EP08775278A patent/EP2182920B1/en active Active
- 2008-07-22 PT PT87752788T patent/PT2182920E/pt unknown
- 2008-07-22 SI SI200831393T patent/SI2494955T1/sl unknown
- 2008-07-22 JP JP2010518618A patent/JP5426548B2/ja active Active
- 2008-07-22 EP EP12170235.1A patent/EP2494955B1/en active Active
- 2008-07-22 AU AU2008281858A patent/AU2008281858B2/en active Active
- 2008-07-22 CA CA2692975A patent/CA2692975C/en active Active
- 2008-07-22 UA UAA201000864A patent/UA102376C2/ru unknown
- 2008-07-22 SI SI200830897T patent/SI2182920T1/sl unknown
- 2008-07-22 KR KR1020107002151A patent/KR101493370B1/ko active Active
- 2008-07-22 GE GEAP200811704A patent/GEP20125525B/en unknown
- 2008-07-22 DK DK08775278.8T patent/DK2182920T3/da active
- 2008-07-22 SG SG2012055679A patent/SG183659A1/en unknown
- 2008-07-22 US US12/667,694 patent/US10292931B2/en active Active
- 2008-07-22 PL PL12170235T patent/PL2494955T3/pl unknown
- 2008-07-22 EA EA201070194A patent/EA016822B1/ru not_active IP Right Cessation
- 2008-07-22 PT PT12170235T patent/PT2494955E/pt unknown
- 2008-07-22 PL PL08775278T patent/PL2182920T3/pl unknown
- 2008-07-22 WO PCT/EP2008/059605 patent/WO2009016069A2/en not_active Ceased
- 2008-07-22 ES ES08775278T patent/ES2399569T3/es active Active
- 2008-07-22 CN CN2008801012992A patent/CN101784257B/zh active Active
- 2008-07-22 ES ES12170235T patent/ES2531241T3/es active Active
- 2008-07-30 AR ARP080103285A patent/AR068327A1/es not_active Application Discontinuation
2010
- 2010-01-06 IL IL203167A patent/IL203167A/en active IP Right Grant
2015
- 2015-03-27 HR HRP20150349TT patent/HRP20150349T1/hr unknown
- 2015-04-09 CY CY20151100342T patent/CY1116189T1/el unknown

Also Published As

Publication number	Publication date
HRP20150349T1 (hr)	2015-05-22
EP2182920B1 (en)	2012-12-26
DK2494955T3 (da)	2015-04-13
AU2008281858B2 (en)	2014-02-27
PL2494955T3 (pl)	2015-06-30
HK1176280A1 (en)	2013-07-26
CN101784257B (zh)	2012-11-28
EA201070194A1 (ru)	2010-06-30
KR101493370B1 (ko)	2015-02-13
US10292931B2 (en)	2019-05-21
JP5426548B2 (ja)	2014-02-26
ITMI20071573A1 (it)	2009-02-01
EP2494955A3 (en)	2012-10-03
WO2009016069A4 (en)	2009-05-14
BRPI0814658A2 (pt)	2015-02-18
SI2182920T1 (sl)	2013-04-30
PT2494955E (pt)	2015-03-04
IL203167A (en)	2017-08-31
PL2182920T3 (pl)	2013-05-31
CN101784257A (zh)	2010-07-21
AU2008281858A1 (en)	2009-02-05
ES2531241T3 (es)	2015-03-12
EP2494955B1 (en)	2015-01-21
GEP20125525B (en)	2012-05-25
HK1138207A1 (en)	2010-08-20
MX2010001092A (es)	2010-03-01
EP2494955A2 (en)	2012-09-05
SG183659A1 (en)	2012-09-27
WO2009016069A3 (en)	2009-03-19
KR20100038112A (ko)	2010-04-12
EP2182920A2 (en)	2010-05-12
ES2399569T3 (es)	2013-04-02
CY1116189T1 (el)	2017-02-08
SI2494955T1 (sl)	2015-04-30
CA2692975A1 (en)	2009-02-05
AR068327A1 (es)	2009-11-11
CA2692975C (en)	2016-01-12
EA016822B1 (ru)	2012-07-30
WO2009016069A2 (en)	2009-02-05
JP2010534703A (ja)	2010-11-11
US20100256159A1 (en)	2010-10-07
PT2182920E (pt)	2013-03-07
UA102376C2 (ru)	2013-07-10

Publication	Publication Date	Title
BRPI0821474A2 (pt)	2017-05-09	formulação farmacêutica líquida estável
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
HRP20250383T3 (hr)	2025-07-18	Tablete koje sadrže eltrombopag olamin
DK2073795T3 (da)	2014-02-03	Misbrugssikret lægemiddelformulation
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
EP3329912C0 (en)	2025-07-23	LIQUID COMPOSITION
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
DK1984009T3 (da)	2013-01-28	Farmaceutiske sammensætninger med forbedret stabilitet
DK2114143T3 (da)	2014-07-07	Flydende sulfonylurea-herbicidformuleringer
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
EP2191826A4 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
BRPI0812354A2 (pt)	2015-01-27	Composição farmacêutica não-aquosa.
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
EP2121716A4 (en)	2013-06-12	COMPOSITIONS OF STABLE TIACUMICINES
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
DK2182920T3 (da)	2013-03-04	Stabil væskeformig farmaceutisk komposition baseret på trazodon
ATE480227T1 (de)	2010-09-15	Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP2116241A4 (en)	2010-07-21	PHARMACEUTICAL COMPOSITION
EP2327406A4 (en)	2014-04-09	STABILIZED PHARMACEUTICAL COMPOSITION